Treatment with inebilizumab was associated with continued improvement in patients with AChR+ generalized myasthenia gravis, according to 52-week results from the MINT trial.
The patients are part of Cabaletta’s RESET program across inflammatory muscle condition myositis ... generalized myasthenia gravis, multiple sclerosis and pemphigus vulgaris (PV) across 50 ...
Hosted on MSN1mon
Study uncovers key factors in myositis-induced muscle weaknessA study has shed new light on the mechanisms behind idiopathic inflammatory myopathies (myositis), a group of systemic autoimmune disorders known for causing severe muscle weakness, fatigue ...
1 Centro Hospitalar de Entre o Douro e Vouga – Physical and Rehabilitation Medicine Department – Santa Maria da Feira, Portugal 2 Physical and Rehabilitation Medicine – Portugal Myositis ossificans ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback